Successful use of recombinant factor VIIa in a preterm infant with life-threatening haematuria

Kirstin Faust*, Birthe Tröger, Fritz Kahl, Marius Schumacher, Wolfgang Göpel, Christoph Härtel

*Korrespondierende/r Autor/-in für diese Arbeit
2 Zitate (Scopus)

Abstract

We report the case of a preterm male infant with a gestational age of 28 + 1 weeks and birth weight of 715 g who presented with life-threatening haematuria on day 28 of life. The haematuria was unresponsive to administration of platelet concentrates and fresh frozen plasma, but then successfully treated with recombinant factor VIIa. The resulting obstructive uropathy was managed by continuous bladder irrigation through suprapubic and urethral catheters. No other adverse affects were noted, and the boy was discharged from the hospital on day 108 of life.

OriginalspracheEnglisch
ZeitschriftBlood Coagulation and Fibrinolysis
Jahrgang20
Ausgabenummer7
Seiten (von - bis)601-604
Seitenumfang4
ISSN0957-5235
DOIs
PublikationsstatusVeröffentlicht - 10.2009

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Successful use of recombinant factor VIIa in a preterm infant with life-threatening haematuria“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren